Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Torlak-300: Phase 3 Trial of Serbian Seasonal Influenza Vaccine
NCT02935192Phase 3Completed
- Sponsor
- Institute Torlak
- Start
- Nov 2016
- Primary completion
- Jan 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of TorVaxFlu in influenza, sponsored by Institute Torlak. Started Nov 2016; status: completed.
02
Drugs
TorVaxFlu
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02935192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02935192.